Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Organoid Kit Market Growth From $1.52 Billion In 2026 To $2.75 Billion By 2030 At A CAGR Of 15.9%
The market for organoid kits has expanded significantly in its size over recent years. The market is anticipated to expand from $1.31 billion in 2025 to $1.52 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.2%. This historical growth can be attributed to several factors including progress in stem cell research, broader utilization in drug discovery, the creation of standardized kits, an increase in biomedical research endeavors, and enhanced financial support for organoid investigations.
The organoid kit market is expected to witness significant expansion in the upcoming years. Its value is projected to reach $2.75 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.9%. This growth during the forecast period can be attributed to several factors including the expansion of personalized medicine, the integration of artificial intelligence in organoid analysis, improvements in microfluidics platforms, the increasing application of regenerative medicine, and enhanced collaborations between pharmaceutical and biotech companies. Key trends anticipated in this period include advancements in 3D cell culture, the development of personalized organoids, microfluidics-based organoid platforms, organoid bioprinting technology, and disease modeling derived from stem cells.
Get A Free Sample Report With In-Depth Market Insights:
Organoid Kit Market Development Factors: What’s Supporting Demand?
The anticipated expansion of the organoid kit market is driven by the rising occurrence of infectious diseases. These diseases are defined as ailments resulting from pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, capable of transmission between individuals either directly or indirectly. The surge in infectious diseases stems from inadequate sanitation and congested living conditions, which facilitate quicker pathogen transmission and elevated infection rates. Organoid kits assist in combating infectious diseases by empowering researchers to create human tissue models in laboratory settings, thereby enabling accurate investigation of pathogen behavior, mechanisms of infection, and evaluation of prospective therapies. For example, data released in August 2024 by the UK Health Security Agency, a UK-based executive agency, revealed that in England, the UKHSA recorded 368 measles cases in 2023. This represented a nearly sevenfold increase from the 53 cases documented in 2022, with the West Midlands contributing 44% and London 33% of these cases, respectively. Consequently, the growing frequency of infectious diseases is propelling the expansion of the organoid kit market.
Organoid Kit Market Segment Breakdown: Which Categories Lead On Revenue?
The organoid kit market covered in this report is segmented –
1) By Type: Brain Organoids, Kidney Organoids, Intestinal Organoids, Liver Organoids, Other Organoid Types
2) By Technology: 3D Cell Culture Technology, Microfluidics Technology
3) By Source: Human-Derived Organoids, Animal-Derived Organoids, Cell Line-Derived Organoids
4) By Application: Drug Discovery and Development, Disease Modeling, Personalized Medicine, Other Applications
5) By End-User: Research Institutes, Pharmaceutical Companies, Contract Research Organizations, Biotech Companies
Subsegments:
1) By Brain Organoids: Cerebral Organoids, Midbrain Organoids, Retinal Organoids
2) By Kidney Organoids: Nephron Organoids, Collecting Duct Organoids, Glomerular Organoids
3) By Intestinal Organoids: Small Intestine Organoids, Colon Organoids, Gastric Organoids
4) By Liver Organoids: Hepatic Organoids, Cholangiocyte Organoids, Biliary Organoids
5) By Other Organoid Types: Pancreatic Organoids, Lung Organoids, Heart Organoids, Tumor Organoids
Organoid Kit Market Transformation Trends: What Innovations Are Driving Change?
Leading companies in the organoid kit market are concentrating on the creation of rapid aggregate formations. This initiative aims to expedite organoid development timelines, enhance reproducibility, and facilitate high-throughput applications for drug discovery, disease modeling, and personalized medicine. Rapid aggregate formation describes the capacity to swiftly produce thousands of uniform pluripotent stem cell aggregates within a single day, substantially shortening organoid development time. For instance, in June 2025, Pluristyx Inc., a US-based biotechnology company, introduced its PluriForm Organoid Kit. This kit was designed to simplify the generation of pluripotent stem cell aggregates and speed up organoid development. The kit features a ready-to-use platform that reduces the duration for creating mature organoids from months to just weeks. It integrates optimized growth media and standardized protocols, which guarantees reproducible outcomes across various cell types. Additionally, it supports high-throughput applications, making it suitable for large-scale disease modeling and drug screening.
Organoid Kit Market Leading Companies And Competitive Benchmarking
Major companies operating in the organoid kit market are STEMCELL Technologies Inc., Bio-Techne Corporation, Takara Bio Inc., American Type Culture Collection (ATCC), ACROBiosystems Inc., MIMETAS B.V., Emulate Inc., CN Bio Innovations Limited, InSCREENeX GmbH, TheWell Bioscience Inc., Prellis Biologics Inc., Crown Bioscience International, AMS Biotechnology (Europe) Limited (AMSBIO), Xylyx Bio Inc., Organovo Holdings Inc., HUB Organoids Holding B.V., Cellesce Ltd., DefiniGEN Ltd., OcellO B.V., AlveoliX AG, VitroLabs Inc.
View The Full Organoid Kit Market Report:
Organoid Kit Market Top Region By Revenue And Market Share
North America was the largest region in the organoid kit market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organoid kit market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model